SWTX SpringWorks Therapeutics Inc
Performance
0% Past Week
Market Cap
1.7B
Day’s Range
52W Range
Volume (3M)
682.25K
Price-Earnings Ratio
-5.3
Revenue
-
About SpringWorks Therapeutics Inc
SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutics enterprise that acquires, develops, and markets medicines for patients within the United States. These therapies target rare diseases and cancers with unmet medical need. The company is headquartered in Stamford, Connecticut, and was established in 2017. The SWTX ticker identifies SpringWorks on the NASDAQ GS. Remain updated on SWTX share price developments by adding this item to your watchlist.
Show More227
Employees
Stamford, Connecticut, US
HQ
2017
Founded
Saqib Islam
CEO
Upcoming Earnings
3
AUG
REPORTS
SpringWorks Therapeutics Inc Q2 2023 earnings report is expected to be released before market open
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
51
Medium
Industry
Avg. 48
34
Environment
40
Social
70
Governance
People Also Bought
- AVXL Anavex Life Sciences Corp -0.97%
- OCUL Ocular Therapeutix Inc -2.37%
- CDXS Codexis Inc -0.78%
- ALVR Allovir Inc -7.83%
IMAB I-Mab-ADR -1.26%